13
Management of Meningiomas

Management of Meningiomas

  • Upload
    nova

  • View
    54

  • Download
    0

Embed Size (px)

DESCRIPTION

Management of Meningiomas. DIAGNOSTIC TOOLS. MRI Dural tail, edema CT SCAN : Hyperostosis, intratumoral calcifications ANGIOGRAPHY: embolization is a consideration tumor blush. DIAGNOSTIC TOOLS. HISTOLOGY Globular, well demarcated Wide dural attachment - PowerPoint PPT Presentation

Citation preview

Page 1: Management of Meningiomas

Management of Meningiomas

Page 2: Management of Meningiomas

DIAGNOSTIC TOOLS

• MRI– Dural tail, edema

• CT SCAN: – Hyperostosis, intratumoral calcifications

• ANGIOGRAPHY: – embolization is a consideration– tumor blush

Page 3: Management of Meningiomas

DIAGNOSTIC TOOLS

• HISTOLOGY– Globular, well demarcated– Wide dural attachment– Invaginated into underlying

brain with no invasion– Cut surface: translucent

pale, homogenously reddish brown,

– Gritty– Meningioma en plaque:

occur as sheet- like extension that covers dura; does not invaginate parenchyma

Page 4: Management of Meningiomas

WHO

GRADE HISTOLOGICAL SUBTYPE

HISTOLOGIC FEATURES

I MENINGOTHELIAL, FIBROBLASTIC, TRANSITIONAL, ANGIOMATOUS, MICROCYSTIC, SECRETORY, LYMPHOPLASMACYTIC, PSAMMOMATOUS

Does not fulfill criteria for grade II or grade III

Page 5: Management of Meningiomas

II (ATYPICAL) CHORDOID, CLEAR CELL 4 or more mitotic cells/ 10 hpf3 or more of ff: -increased cellularity -small cells, necrosis -prominent nucleoli, sheeting -brain invasion in an otherwise Grade 1 tumor

III (ANAPLASTIC) PAPILLARY, RHABDOID 20 or more mitosis/ 10 hpfTumor cells resemble carcinoma, sarcoma or melanoma

IMMUNOCHEMISTRY

(+) Epithelial membrane antigen

(-) anti- Leu 7 antibodies

(+) progesterone, somatostatin receptors

Page 6: Management of Meningiomas

TREATMENT OPTIONS

• SURGERY– Objective: total removal of the meningioma, dural

attachment and bone involved with the tumor– Priority: preserve and improve neurological function

• RADIOTHERAPY– Indications:

• Residual tumor left at operation• Recurrence• Tumors could not be treated surgically• Malignant histology

Page 7: Management of Meningiomas

• OBSERVATION– Asymptomatic patients with little or no edema

in the adjacent brain areas– Patients with mild or minimal symptoms– Older patients with seizure or very slowly

progressing symptoms– Patients in whom treatment carries a

significant risk

Page 8: Management of Meningiomas

FOLLOW- UP

• Multidisciplinary approach for patients with disabilities (e.g. diplopia, dysphasia, dysphagia)

• Regular follow-up with enhanced MRI to check for possible recurrences

• Patients who are discharged home with antiepileptic agents should be monitored

Page 9: Management of Meningiomas

OPERATIVE MEASURES

– Steroids for at least 48 hours; longer with significant brain edema; postoperatively, tapered off over 5 days or longer

– Intravenous antibiotics before operation; 24 hours after the procedure

– Anti- convulsant medications (phenytoin, carbamazepine, valproic acid) for supratentorial operations

Page 10: Management of Meningiomas

TYPES OF RADIATION THERAPY

• EXTERNAL- BEAM RADIATION THERAPY– 5000- 5500 cGy– Daily fractions: 180-200 cGy over 5-6 weeks– Particular care near optic nerves and

brainstem• Radiosurgery: Co- gamma unit

– Dose delivered to margin of tumor : 15-18 Gy– Proximal to optic nerves and chiasm: 9 Gy

Page 11: Management of Meningiomas
Page 12: Management of Meningiomas
Page 13: Management of Meningiomas